Quotient Sciences – UK Headquarters – Nottingham, UK
Mere Way
Ruddington, Nottingham
NG11 6JS
T: +44 115 974 9000
Quotient Sciences – Philadelphia, PA
3080 McCann Farm Drive
Garnet Valley, PA 19060
T: 1 800 769 3518
W: quotientsciences.com
Linkedin: https://www.linkedin.com/company/quotient-sciences
Twitter: https://twitter.com/Quotient_Sci
Facebook: https://www.facebook.com/quotientsciences
Instagram: https://www.instagram.com/quotient_sci
Youtube: https://www.youtube.com/@quotientsciences
Molecule to cure. Fast.
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
Integrated drug development programs
We offer fully integrated development, manufacturing, and clinical testing services for small molecules and peptides at all stages of development.
Translational Pharmaceutics®: Our flagship platform for fully integrated drug development
For over 15 years and over 1,000 molecules, Quotient Sciences’ Translational Pharmaceutics® platform for drug development has helped global pharma and biotechs accelerate their molecule to market. By integrating drug substance, drug product, and clinical testing activities under a single provider, Translational Pharmaceutics® has been proven to shorten development times by an average of 12 months or more, minimize risk and significantly reduce R&D costs.
Our expertise in understanding dependencies between drug substance properties, formulation design, and clinical outcomes enables us to enhance development efficiency. Having both drug substance and drug product manufacturing activities under one organization allows us to deliver integrated chemistry, manufacturing, and controls (CMC) development activities for both pre-clinical and clinical studies in parallel, simplifying the supply chain and improving the likelihood of downstream clinical and commercial success.
Tailored Services
Featured Resources
Posted Date: 11/22/2022
This record has been viewed 4153 times.